Visioneering Technologies, Inc
Clinical trials sponsored by Visioneering Technologies, Inc, explained in plain language.
A medical device company specializing in vision care products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New contact lens trial aims to stop worsening eyesight in children
Disease control OngoingThis study tests whether NaturalVue multifocal contact lenses can slow the progression of myopia (nearsightedness) in children aged 7 to 12. Over three years, 144 kids will wear either standard single-vision lenses or the multifocal lenses. Researchers will measure changes in the…
Sponsor: Visioneering Technologies, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Which contact lens gives sharper vision? new study puts two brands to the test
Symptom relief OngoingThis study compares how well two types of daily disposable multifocal contact lenses work for people with nearsightedness (myopia). Researchers will measure things like sharpness of vision, reading ability, and eye coordination. About 30 people aged 9 to 30 who already wear conta…
Sponsor: Visioneering Technologies, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC